A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable AnginaChristopher Rajkumar, Rasha Al‐Lamee, Tim Kinnaird et al.|New England Journal of Medicine|2023Cited by 223
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trialMichael Foley, Rasha Al‐Lamee, Christopher Rajkumar et al.|The Lancet|2024Cited by 86
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery DiseaseFlorentina Simader, Amit Kaura, Christopher Rajkumar et al.|Journal of the American College of Cardiology|2024Cited by 36
Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery DiseaseChristopher Rajkumar, Rasha Al‐Lamee, Matthew Shun‐Shin et al.|Circulation Cardiovascular Interventions|2021Cited by 19
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery DiseaseMichael Foley, Christopher Rajkumar, Fiyyaz Ahmed‐Jushuf et al.|Circulation|2024Cited by 19